Recommended protocol for the Syrian hamster embryo (SHE) cell transformation assay. 2012

Marie-Aline Maire, and Kamala Pant, and Pascal Phrakonkham, and Albrecht Poth, and Karl-Rainer Schwind, and Claudine Rast, and Shannon Wilson Bruce, and Jamie E Sly, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Markus Schulz, and Paule Vasseur
Université Paul Verlaine de Metz, Metz, France. marie-aline.maire@univ-metz.fr

The Syrian hamster embryo (SHE) cell transformation assay (CTA) is a short-term in vitro assay recommended as an alternative method for testing the carcinogenic potential of chemicals. SHE cells are "normal" cells since they are diploid, genetically stable, non-tumourigenic, and have metabolic capabilities for the activation of some classes of carcinogens. The CTA, first developed in the 1960s by Berwald and Sachs (1963,1964) [3,4], is based on the change of the phenotypic feature of cell colonies expressing the first steps of the conversion of normal to neoplastic-like cells with oncogenic properties. Pienta et al. (1977) [22] developed a protocol using cryopreserved cells to enhance practicality of the assay and limit sources of variability. Several variants of the assay are currently in use, which mainly differ by the pH at which the assay is performed. We present here the common version of the SHE pH 6.7 CTA and SHE pH 7.0 CTA protocols used in the ECVAM (European Centre for the Validation of Alternative Methods) prevalidation study on CTA reported in this issue. It is recommended that this protocol, in combination with the photo catalogues presented in this issue, should be used in the future and serve as a basis for the development of the OECD test guideline.

UI MeSH Term Description Entries
D008647 Mesocricetus A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research. Hamsters, Golden,Hamsters, Golden Syrian,Hamsters, Syrian,Mesocricetus auratus,Syrian Golden Hamster,Syrian Hamster,Golden Hamster,Golden Hamster, Syrian,Golden Hamsters,Golden Syrian Hamsters,Hamster, Golden,Hamster, Syrian,Hamster, Syrian Golden,Syrian Hamsters
D012107 Research Design A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly. Experimental Design,Data Adjustment,Data Reporting,Design, Experimental,Designs, Experimental,Error Sources,Experimental Designs,Matched Groups,Methodology, Research,Problem Formulation,Research Methodology,Research Proposal,Research Strategy,Research Technics,Research Techniques,Scoring Methods,Adjustment, Data,Adjustments, Data,Data Adjustments,Design, Research,Designs, Research,Error Source,Formulation, Problem,Formulations, Problem,Group, Matched,Groups, Matched,Matched Group,Method, Scoring,Methods, Scoring,Problem Formulations,Proposal, Research,Proposals, Research,Reporting, Data,Research Designs,Research Proposals,Research Strategies,Research Technic,Research Technique,Scoring Method,Source, Error,Sources, Error,Strategies, Research,Strategy, Research,Technic, Research,Technics, Research,Technique, Research,Techniques, Research
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000826 Animal Testing Alternatives Procedures, such as TISSUE CULTURE TECHNIQUES; mathematical models; etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories. Alternatives to Animal Testing,Alternative, Animal Testing,Alternatives, Animal Testing,Animal Testing Alternative,Testing Alternative, Animal,Testing Alternatives, Animal
D015197 Carcinogenicity Tests Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values. Tumorigenicity Tests,Carcinogen Tests,Carcinogenesis Tests,Carcinogenic Activity Tests,Carcinogenic Potency Tests,Carcinogen Test,Carcinogenesis Test,Carcinogenic Activity Test,Carcinogenic Potency Test,Carcinogenicity Test,Potency Test, Carcinogenic,Potency Tests, Carcinogenic,Test, Carcinogen,Test, Carcinogenesis,Test, Carcinogenic Activity,Test, Carcinogenic Potency,Test, Carcinogenicity,Test, Tumorigenicity,Tests, Carcinogen,Tests, Carcinogenesis,Tests, Carcinogenic Activity,Tests, Carcinogenic Potency,Tests, Carcinogenicity,Tests, Tumorigenicity,Tumorigenicity Test

Related Publications

Marie-Aline Maire, and Kamala Pant, and Pascal Phrakonkham, and Albrecht Poth, and Karl-Rainer Schwind, and Claudine Rast, and Shannon Wilson Bruce, and Jamie E Sly, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Markus Schulz, and Paule Vasseur
February 2008, Current protocols in toxicology,
Marie-Aline Maire, and Kamala Pant, and Pascal Phrakonkham, and Albrecht Poth, and Karl-Rainer Schwind, and Claudine Rast, and Shannon Wilson Bruce, and Jamie E Sly, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Markus Schulz, and Paule Vasseur
November 2000, Mutation research,
Marie-Aline Maire, and Kamala Pant, and Pascal Phrakonkham, and Albrecht Poth, and Karl-Rainer Schwind, and Claudine Rast, and Shannon Wilson Bruce, and Jamie E Sly, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Markus Schulz, and Paule Vasseur
April 2003, Toxicology letters,
Marie-Aline Maire, and Kamala Pant, and Pascal Phrakonkham, and Albrecht Poth, and Karl-Rainer Schwind, and Claudine Rast, and Shannon Wilson Bruce, and Jamie E Sly, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Markus Schulz, and Paule Vasseur
January 2001, Toxicologic pathology,
Marie-Aline Maire, and Kamala Pant, and Pascal Phrakonkham, and Albrecht Poth, and Karl-Rainer Schwind, and Claudine Rast, and Shannon Wilson Bruce, and Jamie E Sly, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Markus Schulz, and Paule Vasseur
May 1995, Mutation research,
Marie-Aline Maire, and Kamala Pant, and Pascal Phrakonkham, and Albrecht Poth, and Karl-Rainer Schwind, and Claudine Rast, and Shannon Wilson Bruce, and Jamie E Sly, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Markus Schulz, and Paule Vasseur
January 2000, Annals of the New York Academy of Sciences,
Marie-Aline Maire, and Kamala Pant, and Pascal Phrakonkham, and Albrecht Poth, and Karl-Rainer Schwind, and Claudine Rast, and Shannon Wilson Bruce, and Jamie E Sly, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Markus Schulz, and Paule Vasseur
September 1996, Mutation research,
Marie-Aline Maire, and Kamala Pant, and Pascal Phrakonkham, and Albrecht Poth, and Karl-Rainer Schwind, and Claudine Rast, and Shannon Wilson Bruce, and Jamie E Sly, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Markus Schulz, and Paule Vasseur
April 2004, Toxicology in vitro : an international journal published in association with BIBRA,
Marie-Aline Maire, and Kamala Pant, and Pascal Phrakonkham, and Albrecht Poth, and Karl-Rainer Schwind, and Claudine Rast, and Shannon Wilson Bruce, and Jamie E Sly, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Markus Schulz, and Paule Vasseur
September 1996, Mutation research,
Marie-Aline Maire, and Kamala Pant, and Pascal Phrakonkham, and Albrecht Poth, and Karl-Rainer Schwind, and Claudine Rast, and Shannon Wilson Bruce, and Jamie E Sly, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Markus Schulz, and Paule Vasseur
September 1996, Mutation research,
Copied contents to your clipboard!